| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.6390 | 
      | Human Intestinal Absorption | HIA+ | 0.9714 | 
      | Caco-2 Permeability | Caco2- | 0.6631 | 
      | P-glycoprotein Substrate | Substrate | 0.7964 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.8324 | 
                                                     | Inhibitor | 0.6601 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.8617 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.7797 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8503 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.9115 | 
      | CYP450 3A4 Substrate | Substrate | 0.7206 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.8952 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.8909 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.8903 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.8513 | 
      | CYP450 3A4 Inhibitor | Inhibitor | 0.6571 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7992 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8359 | 
                                                                    | Non-inhibitor | 0.6699 | 
      | AMES Toxicity | Non AMES toxic | 0.8927 | 
      | Carcinogens | Non-carcinogens | 0.9523 | 
      | Fish Toxicity | High FHMT | 0.9971 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.9996 | 
      | Honey Bee Toxicity | High HBT | 0.8480 | 
      | Biodegradation | Not ready biodegradable | 0.8854 | 
      | Acute Oral Toxicity | III | 0.3559 | 
      | Carcinogenicity (Three-class) | Non-required | 0.7165 |